Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ceftazidime measurement |
Component |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime poisoning |
Causative agent |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Accidental ceftazidime poisoning |
Causative agent |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Intentional ceftazidime poisoning (disorder) |
Causative agent |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
forgiftning med ceftazidim, uvist med hvilken hensigt |
Causative agent |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime adverse reaction |
Causative agent |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime overdose |
Causative agent |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Accidental ceftazidime overdose |
Causative agent |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Intentional ceftazidime overdose |
Causative agent |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
overdosis af ceftazidim, uvist med hvilken hensigt |
Causative agent |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
ceftazidim 3 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 250 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 2g powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Product containing ceftazidime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime sodium 2g/50 mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 1g/25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 2g/50mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 6g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 1g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 2 g/100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 500mg/15mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 1g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime (arginine formula) 2g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime (arginine formula) 1g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime (arginine formula) 10g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 100 g/hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 6g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime sodium 1g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime sodium 2g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime pentahydrate 2g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 2000 mg infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 10 g infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidimnatrium 20 mg infusionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidimpentahydrat 6 g infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidimpentahydrat 100 mg infusionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 500mg infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidim (med arginin) 10 g/pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidime 1 g/100 ml pulver til injektionsvæske, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 500 mg pulver til injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim (argininformel) 6 g/100 ml, pulver til injektionsvæske, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 2 g/50 ml pulver til injektionsvæske, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime sodium 2g powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime 1g powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 6 g/pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim (med arginin) 1 g/pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime sodium 1g powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime pentahydrate 2g powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidimnatrium 2 g/50 ml opløsning til intravenøs anvendelse, pose a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim (med arginin) 2 g/ pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 500 mg pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 1 g pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 2 g pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Accidental ceftazidime poisoning |
Causative agent |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Intentional ceftazidime poisoning (disorder) |
Causative agent |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Allergy to ceftazidime (finding) |
Causative agent |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Allergy to ceftazidime (finding) |
Causative agent |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Avibactam and ceftazidime |
Is a |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime pentahydrate (substance) |
Is a |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime desensitisation therapy |
Using substance (attribute) |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
2 |
Avibactam and ceftazidime |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime pentahydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime sodium 2g/50 mL conventional release solution for infusion 50mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
ceftazidim 3 g pulver til injektionsvæske, opløsning, hætteglas |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
ceftazidim 1 g pulver til injektionsvæske, rekonstitution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
ceftazidim 250 mg pulver til injektionsvæske, opløsning, hætteglas |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
ceftazidim 500 mg pulver til injektionsvæske, rekonstitution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
ceftazidim 2 g pulver til injektionsvæske, rekonstitution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Product containing only avibactam and ceftazidime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Product containing only avibactam and ceftazidime in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Product containing avibactam and ceftazidime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Avibactam- and ceftazidime-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
|
Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 1 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 1 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 3 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 3 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 2 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 2 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 250 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 250 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Avibactam (as avibactam sodium) 500 mg and ceftazidime 2 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Avibactam (as avibactam sodium) 500 mg and ceftazidime 2 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 1 g powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 1 g powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 2 g powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime 2 g powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |
Ceftazidime therapy (procedure) |
Direct substance |
True |
Ceftazidime (substance) |
Inferred relationship |
Some |
1 |